NCT05359614Unknown不适用
A Single-centered Randomized Single-blinded Clinical Trial to Evaluate Efficacy and Safety of Sequential Treatment of CoolSculpting Elite With CoolTone vs. CoolSculpting Elite Alone in Treating the Banana Roll Region
Goldman, Butterwick, Fitzpatrick and Groff2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2022年3月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 15
- 试验地点
- 2
- 主要终点
- appearance of the banana roll region based on Investigator Global Aesthetic Improvement Scales
研究概览
简要总结
to evaluate the benefit and efficacy of CoolSculpting Elite study treatments versus CoolSculpting Elite study treatments followed by a series CoolTone for underneath the buttocks (also known as the banana roll).
详细描述
Investigate safety and efficacy of CoolSculpting Elite treatments for underneath the buttocks (also known as the banana roll) versus sequential treatments of CoolSculpting Elite and CoolTone for the banana roll region.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 22 Years 至 65 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Inclusion Criteria
- •Female ≥ 22 years and ≤65 years of age.
- •Subject has not had weight change exceeding 5% of body weight in the preceding month.
- •Subject agrees to maintain body weight within 5% during the study by not making any changes in diet or exercise routine.
- •Subject has a BMI ≤ 30 as determined at screening.
- •Subject agrees to have photographs taken of the treatment area(s) during the scheduled time periods.
- •Subject agrees to refrain from any new or change in gluteal muscle training exercises of the treatment area during the course of the study.
- •Subject agrees to avoid sun tanning or spray tanning during the course of the study. Subject has read and signed the study written informed consent form
排除标准
- •Exclusion Criteria
- •Male Subjects
- •Subject has had a recent surgical procedure(s) in the area of intended treatment and muscle contractions may disrupt the healing process.
- •A subject with any uncontrolled systemic disease. A potential subject in whom therapy for a systemic disease is not yet stabilized will not be considered for entry into the study.
- •A subject with a significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
- •Subject has had an invasive fat reduction procedure (e.g., liposuction, mesotherapy) non-invasive fat reduction or skin tightening procedures , or cellulite treatment in the area of intended treatment
- •Subjects who tanned or spray tanned in the treatment area within the past 4 weeks
- •A subject with history of or the presence of any skin condition/disease in the treatment area that might interfere with the diagnosis or evaluation of study parameters (i.e., atopic dermatitis, eczema, psoriasis, seborrheic dermatitis) at the discretion of the investigator.
- •Subject needs to administer or has a known history of subcutaneous injections into the area of intended treatment (e.g., heparin, insulin) within the past month
- •Subject hashad an intrauterine contraceptive device inserted or removed within the past month.
- •A subject with an active bacterial, fungal, or viral infection in the treatment area.
- •Subject has a bleeding disorder
- •Subject has a blood disorder such as cryoglobulinemia, cold agglutinin disease and paroxysmal cold hemoglobinuria.
- •Known sensitivity to cold such as cold urticaria, Raynaud's disease, pernio or Chilblains. Or patients with any impaired sensation in treated area
- •A subject with scarring or tattoos in the treatment area that might interfere with the diagnosis or study evaluations at the discretion of the investigator.
- •Subject is taking or has taken diet pills or supplements within the past month.
- •Subject has a metal implant or active implanted device such as a cardiac pacemaker, cochlear implant, intrathecal pump, hearing aids, defibrillator, or drug delivery system.
- •Subject has pulmonary insufficiency.
- •Subject has a cardiac disorder.
- •Subject has a malignant tumor.
- •Subject has been diagnosed with a seizure disorder such as epilepsy.
- •Subject currently has a fever.
- •Subject is diagnosed with Grave's disease.
- •Subject is pregnant or intending to become pregnant during the study period (in the next 9 months).
- •Subject is lactating or has been lactating in the past 6 months.
- •Subject is unable or unwilling to comply with the study requirements.
- •Subject is currently enrolled in a clinical study of any other investigational drug or device.
- •Current participation or participation within 30 days prior to the start of this study in a drug or other investigational research study.
- •Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject
结局指标
主要结局
appearance of the banana roll region based on Investigator Global Aesthetic Improvement Scales
时间窗: baseline to 18-weeks
Investigator Global Aesthetic Improvement Scale Scores will be assigned where -3 = Very Much Worse, -2 = Much Worse -, -1 = Worse, 0 = No Chance, 1 = Improved, 2 = Much Improved, 3 = Very Much Improved
Improvement in Appearance of the Banana Roll Region Based on Clinical Photographs
时间窗: 18 Weeks
Investigator Global Aesthetic Improvement Scale Scores where -3 = Very Much Worse, -2 = Much Worse -, -1 = Worse, 0 = No Chance, 1 = Improved, 2 = Much Improved, 3 = Very Much Improved will be assigned by a blinded assessor based on photographs
次要结局
- Patient Treatment Satisfaction Survey(baseline to 18-weeks)
- Subject Global Aesthetic Improvement Scale(baseline to 18-weeks)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Analysis of CoolSculpting by Zeltiq for Non-Invasive Cooling of Abdominal Fat Using the eZ App Large ApplicatorAbdominal FatAdipose Tissue, AbdominalNCT01318343Laser and Skin Surgery Center of New York20
已完成
2 期
Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.Acute Respiratory Viral InfectionsHuman InfluenzaNCT04682444Joint Stock Company "Farmak"100
Unknown
不适用
HVPG-Guided Therapy Versus EVL Plus NSBB in Second Prophylaxis of Esophageal Variceal BleedingEsophageal Varices in Cirrhosis of the LiverNCT03687216West China Hospital160
已完成
不适用
Comparison of Clinical Outcomes on Trifocal IOLs FineVision POD F GF and FineVision POD F in Asian EyesLens OpacitiesCataractPresbyopiaNCT03306355Beaver-Visitec International, Inc.45
已完成
3 期
A clinical study to see the effect of Viola Odorata(homoeopathic medicine) in treatment of Chronic BronchitisCTRI/2023/02/049490Dr Ruchita Jerath30